292 related articles for article (PubMed ID: 6182668)
1. Quantitative histophotometry analysing significant inductive and alterative effects of aminoglycoside application (gentamicin, tobramycin, amikacin) upon tubular kidney proteins.
Heinert G; Wyrobnik J; Scherberich J; Mondorf W; Weber W
Urol Int; 1982; 37(4):221-35. PubMed ID: 6182668
[TBL] [Abstract][Full Text] [Related]
2. [Quantitative enzymatic and enzyme histochemical analysis in detecting inductive and nephrotoxic effects of various antibiotics].
Mondorf W; Heinert G
Urologe A; 1983 Jul; 22(4):198-201. PubMed ID: 6137096
[TBL] [Abstract][Full Text] [Related]
3. Quantitative enzymatic histophotometry of morphologic alterations caused by urologically relevant tubular kidney damages using computed image analysis device technique.
Heinert GG; Rauh W; Scherberich JE; Mondorf WA; Weber W
Urol Int; 1981; 36(3):178-93. PubMed ID: 6116305
[TBL] [Abstract][Full Text] [Related]
4. [Functional, histological, biochemical renal modifications. Comparative study of dibekacin, gentamicin, tobramycin, netilmicin and amikacin].
Viotte G; Olier B; Morin JP; Godin M
Nouv Presse Med; 1982 Nov; 11(46):3419-25. PubMed ID: 7155850
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
Drugeon HB; Courtieu AL
Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
[TBL] [Abstract][Full Text] [Related]
6. Early effects of gentamicin, tobramycin, and amikacin on the human kidney.
De Broe ME; Paulus GJ; Verpooten GA; Roels F; Buyssens N; Wedeen R; Van Hoof F; Tulkens PM
Kidney Int; 1984 Apr; 25(4):643-52. PubMed ID: 6482168
[TBL] [Abstract][Full Text] [Related]
7. Acquired cross resistance to aminoglycosides in gentamicin-sensitive and gentamicin-resistant strains of enterobacteria.
Al-Asadi MJ; Towner K; Greenwood D
J Med Microbiol; 1981 May; 14(2):171-83. PubMed ID: 7014903
[TBL] [Abstract][Full Text] [Related]
8. Effect of aminoglycosides on proximal tubular membranes of the human kidney.
Mondorf AW; Breier J; Hendus J; Scherberich JE; Mackenrodt G; Shah PM; Stille W; Schoeppe W
Eur J Clin Pharmacol; 1978 May; 13(2):133-42. PubMed ID: 658110
[TBL] [Abstract][Full Text] [Related]
9. Urinary enzyme release following aminoglycoside administration in single low dose.
Emanuelli G; Anfossi G; Calcamuggi G; Marcarino C; Lanzio M
Enzyme; 1988; 39(2):119-22. PubMed ID: 3396519
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial agents--Part II. The aminoglycosides: streptomycin, kanamycin, gentamicin, tobramycin, amikacin, neomycin.
Brewer NS
Mayo Clin Proc; 1977 Nov; 52(11):675-9. PubMed ID: 336988
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria.
DiPersio JR; Krafczyk TL
Chemotherapy; 1980; 26(5):323-33. PubMed ID: 7389428
[TBL] [Abstract][Full Text] [Related]
12. Aminoglycoside resistance in gram-negative bacilli during increased amikacin use. Comparison of experience in 14 United States hospitals with experience in the Minneapolis Veterans Administration Medical Center.
Gerding DN; Larson TA
Am J Med; 1985 Jul; 79(1A):1-7. PubMed ID: 4025364
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
[TBL] [Abstract][Full Text] [Related]
14. Global and effective synergism of amikacin, gentamicin or tobramycin when combined with carbenicillin against Pseudomonas aeruginosa.
Ximenes J; Hirai CK; Takenaka IM
J Int Med Res; 1979; 7(5):375-8. PubMed ID: 115732
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity, synergism, and testing parameters of amikacin, with comparisons to other aminoglycoside antibiotics.
Kelly MT; Matsen JM
Antimicrob Agents Chemother; 1976 Mar; 9(3):440-7. PubMed ID: 1259402
[TBL] [Abstract][Full Text] [Related]
16. Transduction of amikacin, gentamicin and tobramycin resistance in Pseudomonas aeruginosa with phage F 116 and AP 19, a new wildtype phage.
Knothe H; Lebek G; Krcméry V; Seginková Z; Cervenka J; Antal M; Mitsuhashi S
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):506-10. PubMed ID: 6800151
[TBL] [Abstract][Full Text] [Related]
17. Gentamicin-resistant gram-negative bacilli in hospital patients. Part II. In vitro aspects including susceptibility to tobramycin and amikacin.
Block CS; Fabian B; Robinson RG
S Afr Med J; 1978 Mar; 53(11):396-99. PubMed ID: 675374
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro activity of netilmicin, amikacin, tobramycin and sisomicin against gentamicin highly-resistant enterobacteriaceae.
Tselentis J; Legakis NJ; Nicolas KJ; Melissinos K; Papavassiliou J
Chemotherapy; 1980; 26(6):409-17. PubMed ID: 7408554
[TBL] [Abstract][Full Text] [Related]
19. Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.
Washington JA; Snyder RJ; Kohner PC; Wiltse CG; Ilstrup DM; McCall JT
J Infect Dis; 1978 Feb; 137(2):103-11. PubMed ID: 415096
[TBL] [Abstract][Full Text] [Related]
20. Transduction of amikacin, gentamicin and tobramycin resistance in Pseudomonas aeruginosa.
Knothe H; Krcméry V; Mitsuhashi S
Zentralbl Bakteriol A; 1980 Mar; 246(3):373-8. PubMed ID: 6775445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
